title: [Major hypertriglyceridemia on tamoxifen].
authors: Service ďEndocrinologie Diabétologie et Nutrition, CHU Hassan II, Fès, Maroc.
authors: Youssef
authors: Y
authors: Khabbal
authors: Hanane
authors: H
authors: El Ouahabi
authors: Salma
authors: S
authors: Bensbaa
authors: Loubna
authors: L
authors: Agerd
authors: Sami
authors: S
authors: Brahmi
authors: Omar
authors: O
authors: ElMesbahi
authors: Farida
authors: F
authors: Ajdi
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000139:chemically induced* / Q000503:physiopathology; D012720:Severity of Illness Index; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen
keywords: Hypertriglycéridémie; hypertriglyceridemia; pharmacovigilance; tamoxifen; tamoxifène
references: Cancer. 1986 Jun 1;57(11):2123-6
references: 3697911
references: J Chemother. 2002 Jun;14(3):309-11
references: 12120888
references: Clin Drug Investig. 2006;26(5):297-302
references: 17163263
references: J Clin Endocrinol Metab. 1998 May;83(5):1633-5
references: 9589669
references: Br J Surg. 1987 Jul;74(7):586-7
references: 3620865
references: JOP. 2010 Jul 05;11(4):382-4
references: 20601815
references: Clin Oncol (R Coll Radiol). 1998;10(4):270-1
references: 9764383
references: Dig Dis Sci. 2004 Jun;49(6):997-9
references: 15309890
references: Ann Oncol. 2000 Aug;11(8):1067-9
references: 11038048
references: N Engl J Med. 2001 Jun 28;344(26):1997-2008
references: 11430330